Exscientia plc(US:EXAI) Prnewswireยท2024-06-06 15:10Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Exscientia plc due to allegations of misconduct by its executives, with a federal securities class action already filed against the company, and a deadline for investors to seek lead plaintiff status set for June 25, 2024 [1][10]. Group 1: Company Background and Legal Context - Exscientia's stock price experienced a significant decline of $1.72 per share, or 22.9%, closing at $5.79 per share on February 13, 2024, following the announcement of executive terminations [3]. - The investigation centers around the termination of CEO Dr. Hopkins for engaging in inappropriate relationships with employees, which the Board deemed inconsistent with the company's standards [7]. - Dr. Nicholson, another executive, resigned after it was revealed he had prior knowledge of Dr. Hopkins's misconduct and addressed it without consulting the Board [7][10]. Group 2: Allegations and Legal Claims - The complaint alleges that Exscientia and its executives violated federal securities laws by making false or misleading statements and failing to disclose the inappropriate relationships and inadequate enforcement of the company's Code of Business Conduct and Ethics [10]. - The allegations suggest that these failures exposed the company to risks of leadership disruptions and reputational harm, leading to materially false public statements [10]. - Investors who suffered losses exceeding $75,000 between March 23, 2022, and February 12, 2024, are encouraged to contact Faruqi & Faruqi to discuss their legal options [6].